Pulmatrix Inc logo

Pulmatrix Inc

$ 3.61 -0.1 (-2.7%) 10:08 PM EST
P/E:
At Loss
P/B:
0.32
Market Cap:
$ 12.23M
Enterprise V:
$ -28.98M
Volume:
57.64K
Avg Vol (2M):
183.04K
Also Trade In:
Volume:
57.64K
Market Cap $:
12.23M
PE Ratio:
At Loss
Avg Vol (2-Month):
183.04K
Enterprise Value $:
-28.98M
PB Ratio:
0.32
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Name Current Vs Industry Vs History
Cash-To-Debt 25.21
Equity-to-Asset 0.78
Debt-to-Equity 0.04
Debt-to-EBITDA -0.1
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.21
Distress
Grey
Safe
Beneish M-Score -3.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 10.67
9-Day RSI 21.07
14-Day RSI 28.82
6-1 Month Momentum % -31.29
12-1 Month Momentum % -70.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.19
Quick Ratio 8.19
Cash Ratio 7.66
Days Sales Outstanding 65.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -135.5

Financials (Next Earnings Date:2022-11-10 Est.)

PULM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PULM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.016
EPS (TTM) ($) -8.5
Beta 1.09
Volatility % 51.03
14-Day RSI 28.82
14-Day ATR ($) 0.325203
20-Day SMA ($) 4.26834
12-1 Month Momentum % -70.06
52-Week Range ($) 3.5 - 20.8
Shares Outstanding (Mil) 3.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pulmatrix Inc Filings

Document Form Filing Date
No Filing Data

Pulmatrix Inc Analysis

Share your research

Headlines

See More
No news.